A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors. Phase 1 first-in-human study of PF-07257876, a novel CD47/PD-L1 bispecific checkpoint inhibitor, in patients ...
Safety of immune checkpoint inhibitors in patients with preexisting autoimmune disorders. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not include a full ...
See CONTRIBUTING.md for a list of requirements to contribute to this track. It also has a list of tools you can use, of which the test tool is one of them.
This project uses eslint to help you write quality JavaScript code by checking for common formatting errors, enforcing style rules, and suggesting changes that conform to best practices. Note: make ...
The PAYNTR X 002 LE impressed with a runner up finish in the Most Wanted Spikeless Shoe of 2024 test. Comfort and traction are its two strong suits.